Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Remegen's Innovative New Drug Telitacicept(RC18) Obtains Positive Phase III Results, Submitted for Second Indication for Treatment of Rheumatoid Arthritis 2023-09-27 09:30
SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference 2023-09-27 08:30
Latest Updates of Viva's Portfolio Companies 2023-09-26 21:06
YS Biopharma Announces First Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine 2023-09-26 20:30
WuXi Vaccines Launches Its First Vaccines CDMO Site in China 2023-09-26 15:41
Ascletis Announces Completion of Enrollment of 120 Patients in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma 2023-09-26 08:10
Chime Biologics Enters into a Strategic Cooperation Agreement with Korea Kings Pharm to Accelerate the Biosimilar Launch 2023-09-25 20:15
Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology 2023-09-25 19:00
AffaMed Therapeutics Announces Clinical Trial Application Approval in Mainland China for Risuteganib (Luminate®) First-in-Class Candidate for the Treatment of Intermediate Dry AMD 2023-09-25 09:00
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC 2023-09-25 07:41
MediLink Therapeutics: Focuses on ADC research and development to promote new prospects for cancer treatment 2023-09-23 18:29
Chime Biologics Announced Global Strategic Cooperation with Panolos Bioscience to Advance Multi-specific Therapeutic Proteins Development 2023-09-22 20:15
MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil 2023-09-22 16:41
FDA Grants Fast Track Designation to 9MW3011 2023-09-22 08:00
Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function 2023-09-21 21:00
Golidocitinib Granted Priority Review by China NMPA for the Treatment of r/r PTCL 2023-09-21 20:26
VEDU Announces New Business Development and Management Team Changes 2023-09-21 20:00
AVANCE CLINICAL APPOINTS US-BASED EXECUTIVES - SVP SCIENTIFIC AND REGULATORY AFFAIRS, AND DIRECTOR BUSINESS DEVELOPMENT 2023-09-21 19:30
Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031 2023-09-21 18:05
Two Cases of Pancreatic Cancer Treatment with CARsgen's CT041 Published in Journal of Hematology & Oncology 2023-09-21 16:00
1 79 80 81 82 83 452